News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Kalkine Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations after the FDA issued a warning letter on June 2, 2026, citing significant violations of manufacturing regulations. This news caused Medline's stock to drop by 7.16%. The investigation …
Image source: The Motley Fool. DATE Wednesday, August 5, 2026 at 9:30 a.m. ET CALL PARTICIPANTS Global Head of Investor Relations - Karen King Chief Executive Officer - James Boyle Chief Financial Officer - Michael Drazin Full Conference Call Transcript Operator: Good morning, and …
Hellman & Friedman-affiliated investment vehicles have updated their ownership report for Medline Inc., indicating beneficial ownership of 153,327,675 shares of Class A common stock as of June 30, 2026. This represents up to 16.0% of the class for certain entities and includes shares already …
GIC Private Ltd, a significant owner and director of Medline Inc. (MDLN), sold 590,284 shares of Class A Common Stock for approximately $21 million on August 7, 2026. Following these transactions, GIC Private Ltd directly holds over 24 million shares and indirectly holds an …
Blackstone-affiliated entities and Stephen A. Schwarzman have filed an updated ownership report for Medline Inc. (MDLN), revealing a beneficial ownership of 153,327,675 shares of Class A common stock, which represents a 16.5% stake. This ownership includes Class A shares and Common Units exchangeable into …
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (MDLN) following a warning letter from the FDA regarding "significant violations of Current Good Manufacturing Practice regulations" and inadequate cleaning practices. The FDA letter, dated May 28, 2026, led to a …
Entities affiliated with GIC Private Ltd, GIC Special Investments Pte Ltd, and Hux Investment Pte. Ltd. sold 2,248,612 shares of Medline Inc. (MDLN) Class A Common Stock on August 5-6, 2026, at weighted-average prices in the mid-$30s. Despite the sale, these entities retain a …
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by Medline Inc. (NASDAQ: MDLN) after an FDA warning letter disclosed significant violations of manufacturing practice regulations. The FDA cited the company for failing to thoroughly investigate discrepancies and microbial contamination incidents, leading …
FMR LLC has disclosed a 5.5% ownership stake in Medline Inc.'s Class A common stock, totaling 46,929,203.69 shares as of June 30, 2026. Abigail P. Johnson, controlling FMR LLC, holds sole dispositive power over these shares. The filing indicates sole voting power over 45,718,763.34 …
Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by Medline Inc. (NASDAQ: MDLN) following significant FDA warning letters regarding manufacturing practice violations. Medline's stock price dropped over 7% after the initial FDA news and an additional 12% after disappointing …
Medline Inc. (Nasdaq: MDLN) reported an 11.6% increase in Q2 2026 net sales to $7.7 billion, and an 11.1% increase for the first six months to $15.0 billion. Despite strong sales growth, net income for Q2 dropped 58.3% to $139 million and 42.3% for …
Medline reported strong revenue and adjusted EBITDA growth of 12% and 13% respectively in the second quarter. Despite raising organic sales growth outlook, the adjusted EBITDA margin outlook was lowered, leading to a 13% drop in shares. The author suggests the selloff might be …
Medline, the largest provider of medical-surgical products in the US, continues to expand its customer base and maintain high retention rates with prime vendor relationships, which account for over 60% of its revenue. Despite solid sales momentum and a strategy to increase brand penetration …
Key Points Interested in Medline? Here are five stocks we like better. Medline reported strong second-quarter growth, with net sales up 12% to $7.7 billion, led by a 16% increase in Supply Chain Solutions and a 15% increase in U.S. acute-care sales. The company …
Insulet stock crashed Wednesday after lowering sales guidance for its body-worn insulin pump, Omnipod, in the back half of the year. Continue Reading
Approximately 497.8 million Class A Common Stock of Medline Inc. are under a lock-up agreement that concludes on August 5, 2026. This agreement, spanning 76 days from May 21, 2026, restricts officers, directors, principal stockholders, and pre-IPO investors from selling or hedging their shares …
Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (MDLN) for potential securities law violations following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and "inadequate cleaning practices," which led to a 7.16% drop in …
This article provides a detailed overview of Medline Ord Shs Class A (MDLN), including its current market price, key financial figures, and recent news. It highlights analyst ratings, peer comparisons, and technical indicators, with Medline receiving a "Buy" rating from analysts. The article also …
Key Points Interested in Ranpak Holdings Corp? Here are five stocks we like better. Automation drove Q2 growth: Revenue rose 12.2% year over year on a constant-currency basis, while automation revenue increased 139%, supported by deployments with Walmart and Medline and new customer wins. …
Kaplan Fox & Kilsheimer LLP has initiated an investigation into Medline Inc. (MDLN) for potential securities law violations following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and inadequate investigations of discrepancies and contamination incidents, …
Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations following a June 2, 2026 FDA warning letter citing "significant violations of Current Good Manufacturing Practice regulations" and inadequate investigation into manufacturing issues. This news led to a …
This article provides a detailed overview of Medline Ord Shs Class A (MDLN) on TradingKey, including its current stock price, market capitalization, and P/E ratio. It highlights that no stock score is currently available due to insufficient data but explains how TradingKey generally generates …
This article provides a revenue breakdown for Medline, Inc. Class A (XETR:L10). In the last fiscal year, the company generated 24.21 billion EUR, with its Supply Chain Solutions segment contributing the most at 12.53 billion EUR. The United States was the largest regional contributor, …
Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations after the FDA issued a warning letter on June 2, 2026, citing significant violations of current good manufacturing practice regulations for finished pharmaceuticals. The FDA stated that Medline …
Kaplan Fox & Kilsheimer LLP has launched a securities investigation into Medline Inc. (MDLN) following an FDA warning letter detailing significant violations of manufacturing practice regulations, leading to a 7.16% drop in Medline's stock price. The firm is encouraging investors who have suffered losses …
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (NASDAQ: MDLN) following a Federal Drug Administration (FDA) warning letter. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and "inadequate cleaning practices" which led to a 7.16% drop …
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (NASDAQ: MDLN) after the FDA issued a warning letter on May 28, 2026, citing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals." Following this news, Medline's stock price …
Search by ticker symbol or company name and select a result to open its chart.